Latest news
Innovent, Daiichi Sankyo Partner to Commercialise Vanflyta for FLT3-ITD Positive AML in China - BioPharma APACBioPharma APAC · Mon, 10 Aug 2026 18:33:43 GMTInnovent Doses First Patient in Phase 3 Trial of IBI363 for Advanced Colorectal Cancer - BioPharma APACBioPharma APAC · Sat, 08 Aug 2026 16:11:09 GMT